Transforming evidence into answers: An agentic framework to support living clinical practice guidelines.

S Syed Arsalan Ahmed Naqvi (Mayo Clinic, Phoenix, AZ) M Muhammad Ali Khan F Fouad Nahhat (1Mayo Clinic, Division of Hematology/Oncology, Department of Internal Medicine, Phoenix, United States) M Muhammad Uzair Sarfraz (1Mayo Clinic, Division of Hematology/Oncology, Department of Internal Medicine, Phoenix, United States) P Priya Kumar B Bryan Bryan Rumble (ASCO, Alexandria, VA) T Tom Oliver (ASCO, Alexandria, VA) I Irbaz Bin Riaz (Irbaz Bin Riaz, MD, PhD; R. Bryan Rumble, MSc; Thomas A. Hope, MD; Giuseppe Procopio, MD; and Neha Vapiwala, MD; Mayo Clinic, Phoenix, AZ; American Society of Clinical Oncology, Alexandria, VA; University of California, San Francisco, San Francisco, CA; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; and University of Pennsylvania Abramson Cancer Center, Philadelphia, PA) H Huan He (National Engineering Laboratory for Druggable Gene and Protein Screening, College of Life Science, Northeast Normal University)

Abstract

e17004 Background: Living clinical practice guidelines offer the opportunity to keep recommendations aligned with the latest evidence, but they also present a fundamental challenge: as evidence accumulates, panelists cannot sustainably query and synthesize a growing body of literature. In developing ASCO's living metastatic castration-resistant prostate cancer (mCRPC) guideline, we encountered this challenge firsthand. To address it, we developed and evaluated an interactive agentic framework that enables guideline panelists to query evidence in natural language and retrieve structured facts, tables, and figures—with the goal of extending this tool as a clinician-facing companion to enhance guideline accessibility. Methods: The mCRPC systematic review dataset supporting ASCO's clinical practice guideline was used, comprising 212 structured columns capturing trial characteristics, patient populations, and outcomes extracted from 188 references across 88 clinical trials. A large language model (LLM)-based agentic framework was developed employing a coding agent that translates natural language queries into executable scripts for structured evidence retrieval. Claude (Haiku 4.5, Sonnet 4.5, and Opus 4.5) served as the core LLM agents. We constructed a benchmark of 50 fact-based queries with gold-standard answers targeting trial identification, treatment modalities, and endpoint characteristics (e.g., "Which trials evaluated systemic monotherapy?"). Performance was evaluated using exact-match accuracy for final answers, and precision, recall, and F1 score for trial-level retrieval. Results: Across 50 queries, exact-match accuracy ranged from 82% to 86%. Haiku 4.5 and Sonnet 4.5 each achieved 82% (42/50), while Opus 4.5 achieved 86% (43/50). Precision ranged from 0.93–0.97, recall from 0.94–0.96, and F1 scores from 0.91–0.94. Conclusions: This agentic framework enables scalable, auditable, natural language interrogation of guideline evidence, addressing a critical bottleneck in living guideline maintenance. For panelists, it supports rapid, reproducible evidence surveillance during recommendation development. For clinicians, it offers a foundation for an interactive companion tool that transforms static guidelines into queryable resources—enabling personalized evidence retrieval at the point of care. LLM EM Precision Recall F1 claude-haiku-4-5 0.82(42/50) 0.95 0.94 0.91 claude-sonnet-4-5 0.82(42/50) 0.97 0.96 0.93 claude-opus-4-5 0.86(43/50) 0.93 0.96 0.94

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (9)

S

Syed Arsalan Ahmed Naqvi

Mayo Clinic, Phoenix, AZ

M

Muhammad Ali Khan

F

Fouad Nahhat

1Mayo Clinic, Division of Hematology/Oncology, Department of Internal Medicine, Phoenix, United States

M

Muhammad Uzair Sarfraz

1Mayo Clinic, Division of Hematology/Oncology, Department of Internal Medicine, Phoenix, United States

P

Priya Kumar

B

Bryan Bryan Rumble

ASCO, Alexandria, VA

T

Tom Oliver

ASCO, Alexandria, VA

I

Irbaz Bin Riaz

Irbaz Bin Riaz, MD, PhD; R. Bryan Rumble, MSc; Thomas A. Hope, MD; Giuseppe Procopio, MD; and Neha Vapiwala, MD; Mayo Clinic, Phoenix, AZ; American Society of Clinical Oncology, Alexandria, VA; University of California, San Francisco, San Francisco, CA; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; and University of Pennsylvania Abramson Cancer Center, Philadelphia, PA

H

Huan He

National Engineering Laboratory for Druggable Gene and Protein Screening, College of Life Science, Northeast Normal University